James CD - Search Results

1

NT113, a pan-ERBB inhibitor with high brain penetrance, inhibits the growth of glioblastoma xenografts with EGFR amplification.

Yoshida Y, Ozawa T, Yao TW, Shen W, Brown D, Parsa AT, Raizer JJ, Cheng SY, Stegh AH, Mazar AP, Giles FJ, Sarkaria JN, Butowski N, Nicolaides T, James CD. Yoshida Y, et al. Among authors: james cd. Mol Cancer Ther. 2014 Dec;13(12):2919-29. doi: 10.1158/1535-7163.MCT-14-0306. Epub 2014 Oct 13. Mol Cancer Ther. 2014. PMID: 25313012 Free PMC article.

2

PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.

Liu W, James CD, Frederick L, Alderete BE, Jenkins RB. Liu W, et al. Among authors: james cd. Cancer Res. 1997 Dec 1;57(23):5254-7. Cancer Res. 1997. PMID: 9393744

3

Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer.

Couch FJ, Wang XY, Wu GJ, Qian J, Jenkins RB, James CD. Couch FJ, et al. Among authors: james cd. Cancer Res. 1999 Apr 1;59(7):1408-11. Cancer Res. 1999. PMID: 10197603

4

Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.

Frederick L, Wang XY, Eley G, James CD. Frederick L, et al. Among authors: james cd. Cancer Res. 2000 Mar 1;60(5):1383-7. Cancer Res. 2000. PMID: 10728703

5

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

Smith JS, Tachibana I, Passe SM, Huntley BK, Borell TJ, Iturria N, O'Fallon JR, Schaefer PL, Scheithauer BW, James CD, Buckner JC, Jenkins RB. Smith JS, et al. Among authors: james cd. J Natl Cancer Inst. 2001 Aug 15;93(16):1246-56. doi: 10.1093/jnci/93.16.1246. J Natl Cancer Inst. 2001. PMID: 11504770

6

Combination of epidermal growth factor receptor targeted therapy with radiation therapy for malignant gliomas.

Krishnan S, Rao RD, James CD, Sarkaria JN. Krishnan S, et al. Among authors: james cd. Front Biosci. 2003 Jan 1;8:e1-13. doi: 10.2741/895. Front Biosci. 2003. PMID: 12456322 Review.

7

Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.

Giannini C, Sarkaria JN, Saito A, Uhm JH, Galanis E, Carlson BL, Schroeder MA, James CD. Giannini C, et al. Among authors: james cd. Neuro Oncol. 2005 Apr;7(2):164-76. doi: 10.1215/S1152851704000821. Neuro Oncol. 2005. PMID: 15831234 Free PMC article.

8

Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells.

Rao RD, Mladek AC, Lamont JD, Goble JM, Erlichman C, James CD, Sarkaria JN. Rao RD, et al. Among authors: james cd. Neoplasia. 2005 Oct;7(10):921-9. doi: 10.1593/neo.05361. Neoplasia. 2005. PMID: 16242075 Free PMC article.

9

Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response.

Sarkaria JN, Carlson BL, Schroeder MA, Grogan P, Brown PD, Giannini C, Ballman KV, Kitange GJ, Guha A, Pandita A, James CD. Sarkaria JN, et al. Among authors: james cd. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2264-71. doi: 10.1158/1078-0432.CCR-05-2510. Clin Cancer Res. 2006. PMID: 16609043

10

Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel.

Sarkaria JN, Yang L, Grogan PT, Kitange GJ, Carlson BL, Schroeder MA, Galanis E, Giannini C, Wu W, Dinca EB, James CD. Sarkaria JN, et al. Among authors: james cd. Mol Cancer Ther. 2007 Mar;6(3):1167-74. doi: 10.1158/1535-7163.MCT-06-0691. Mol Cancer Ther. 2007. PMID: 17363510

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

370 results

Search Page

Filters